Please use this identifier to cite or link to this item: https://doi.org/10.1371/journal.pone.0201342
DC FieldValue
dc.titleProspective cohort study of corneal endothelial cell loss after Baerveldt glaucoma implantation
dc.contributor.authorIwasaki K.
dc.contributor.authorArimura S.
dc.contributor.authorTakihara Y.
dc.contributor.authorTakamura Y.
dc.contributor.authorInatani M.
dc.date.accessioned2019-11-01T08:13:52Z
dc.date.available2019-11-01T08:13:52Z
dc.date.issued2018
dc.identifier.citationIwasaki K., Arimura S., Takihara Y., Takamura Y., Inatani M. (2018). Prospective cohort study of corneal endothelial cell loss after Baerveldt glaucoma implantation. PLoS ONE 13 (7) : e0201342. ScholarBank@NUS Repository. https://doi.org/10.1371/journal.pone.0201342
dc.identifier.issn19326203
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/161221
dc.description.abstractPurpose To evaluate corneal endothelial cell loss after Baerveldt glaucoma implantation. Methods We prospectively evaluated changes in endothelial cell density (ECD) in the cornea of 59 patients (59 eyes) who underwent Baerveldt glaucoma implantation. Tubes were inserted into the anterior chamber in 45 eyes and pars plana in 14 eyes. The primary outcome measure was the change in corneal ECD after Baerveldt glaucoma implantation. Secondary outcome measures included relationships between corneal ECD and optical coherence tomography images of tube parameters (tube–cornea distance and tube–cornea angle) and prognostic factors for corneal ECD loss. Results Corneal ECD decreased significantly by 9.2% at 12 months after surgery (P = 0.001). In the anterior chamber Baerveldt glaucoma implantation group, corneal ECD at the tube insertion quadrant decreased significantly by 9.6% at 3 months (P = <0.001), 10.7% at 6 months (P = <0.001), and 13.1% at 12 months (P = <0.001). Corneal ECD at the center decreased significantly at 6 months after surgery (7.2% loss; P = 0.012) and at 12 months after surgery (12.1% loss; P = 0.001). Corneal ECD at the contralateral quadrant decreased significantly at 12 months after surgery only (10.3% loss; P = 0.004). In the pars plana Baerveldt glaucoma implantation group, no significant loss of corneal ECD was found in any corneal areas at any post-surgery follow-up visits. Tube-cornea angle was negatively correlated with the rate of corneal ECD loss at the tube insertion quadrant; r = ?0.55 (P = 0.0013). In multivariable analyses, exfoliation glaucoma and narrower tube–cornea angle were significant prognostic factors for severe corneal ECD loss (P = 0.0068 and P = 0.046, respectively). Conclusions Anterior chamber Baerveldt glaucoma implantation causes corneal endothelial cell loss. Corneal endothelial cell loss starts at the tube insertion quadrant. Exfoliation glaucoma and narrower tube-corneal angle are associated with severe loss of corneal endothelial cells. © 2018 Iwasaki et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceUnpaywall 20191101
dc.subjectadult
dc.subjectaged
dc.subjectanterior eye chamber
dc.subjectArticle
dc.subjectcohort analysis
dc.subjectcorneal endothelial cell loss
dc.subjecteye surgery
dc.subjectfemale
dc.subjectfollow up
dc.subjecthuman
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectpars plana vitrectomy
dc.subjectprognosis
dc.subjectpseudoexfoliation
dc.subjectrisk factor
dc.subjecttreatment outcome
dc.subjectadverse device effect
dc.subjectclinical trial
dc.subjectcomplication
dc.subjectcorneal endothelial cell loss
dc.subjectglaucoma
dc.subjectglaucoma drainage implant
dc.subjectmiddle aged
dc.subjectpathology
dc.subjectprospective study
dc.subjectvery elderly
dc.subjectAged
dc.subjectAged, 80 and over
dc.subjectCorneal Endothelial Cell Loss
dc.subjectFemale
dc.subjectGlaucoma
dc.subjectGlaucoma Drainage Implants
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectProspective Studies
dc.subjectTreatment Outcome
dc.typeArticle
dc.contributor.departmentCANCER SCIENCE INSTITUTE OF SINGAPORE
dc.description.doi10.1371/journal.pone.0201342
dc.description.sourcetitlePLoS ONE
dc.description.volume13
dc.description.issue7
dc.description.pagee0201342
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1371_journal_pone_0201342.pdf2.68 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons